Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.

Literature DB >> 5272336

Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.

D L Morton, F R Eilber, W L Joseph, W C Wood, E Trahan, A S Ketcham.

Abstract

Entities: Disease Species

Mesh：

Substances：
BCG Vaccine

Year: 1970 PMID： 5272336 PMCID： PMC1397284 DOI： 10.1097/00000658-197010000-00018

Source DB: PubMed Journal: Ann Surg ISSN： 0003-4932 Impact factor: 12.969

× No keyword cloud information.

32 in total

1. Protective activity of fractions of tubercle bacilli against isologous tumours in mice.

Authors: D W WEISS; R S BONHAG; K B DEOME
Journal: Nature Date: 1961-06-03 Impact factor: 49.962

2. Spontaneous regression of human melanoma: clinical and experimental studies.

Authors: W C SUMNER; A G FORAKER
Journal: Cancer Date: 1960 Jan-Feb Impact factor: 6.860

3. Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures.

Authors: G Klein; P Clifford; E Klein; R T Smith; J Minowada; F M Kourilsky; J H Burchenal
Journal: J Natl Cancer Inst Date: 1967-11 Impact factor: 13.506

4. Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors: G Henle; W Henle
Journal: J Bacteriol Date: 1966-03 Impact factor: 3.490

5. Demonstration of antibodies against human malignant melanoma by immunofluorescence.

Authors: D L Morton; R A Malmgren; E C Holmes; A S Ketcham
Journal: Surgery Date: 1968-07 Impact factor: 3.982

6. Immunofluorescent studies of antibodies against human malignant melanoma.

Authors: M M Romsdahl; I S Cox
Journal: Surg Forum Date: 1969

7. Further observations on the immunofluorescence of cells in human leukemia.

Authors: M A Fink; M Karon; F J Rauscher; R A Malmgren; H C Orr
Journal: Cancer Date: 1965-10 Impact factor: 6.860

Review 8. Tumor antigens.

Authors: G Klein
Journal: Annu Rev Microbiol Date: 1966 Impact factor: 15.500

9. Spontaneous regression of cancer.

Authors: T C Everson
Journal: Ann N Y Acad Sci Date: 1964-04-02 Impact factor: 5.691

10. Clinical immunologic study of malignant disease: response to tumor transplants and transfer of leukocytes.

Authors: S H Nadler; G E Moore
Journal: Ann Surg Date: 1966-09 Impact factor: 12.969

25 in total

Review 1. State of melanoma: an historic overview of a field in transition.

Authors: Vikram C Gorantla; John M Kirkwood
Journal: Hematol Oncol Clin North Am Date: 2014-06 Impact factor: 3.722

Review 2. [The immunology of malignant melanoma (author's transl)].

Authors: G Schieferstein
Journal: Klin Wochenschr Date: 1978-03-15

3. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.

Authors: E Yarkoni; L Peters; H J Rapp; M G Hanna; J T Hunter
Journal: Infect Immun Date: 1979-05 Impact factor: 3.441

4. The role of circulating antibody in the control of metastases.

Authors: M G Lewis
Journal: J Clin Pathol Suppl (R Coll Pathol) Date: 1974

5. Immune therapy of malignant melanoma.

Authors:
Journal: Can Med Assoc J Date: 1972-09-09 Impact factor: 8.262

6. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.

Authors: R L Simmons; A Rios
Journal: Ann Surg Date: 1972-08 Impact factor: 12.969